Clifton Mining Company Inc. (OTC : CFTN) ALPINE, UT, Feb. 8 /PRNewswire-FirstCall/ -- American Biotech Labs (ABL), a private company (Clifton Mining Company owns 22% of ABL) announces that they have just signed a joint venture with International Minerals and Metals, Inc. (IMM), to develop markets in 59 countries. The New Venture --------------- IMM is a private international company that has built a longstanding network of joint ventures in 59 countries, under the direction of its chairman Mr. Philip M. Lynch. This joint venture network will become the basis for the next round of sales growth for ABL as well as for humanitarian aid purposes. Over the last year, the management of ABL has personally met with many of these joint venture partners in Dubai, Singapore, China, India, and Europe, etc., in preparation for the new ABL/IMM joint venture. Management Comment ------------------ The management of ABL feels that this joint venture will open doors in numerous countries world wide, where the SilverSol Technology(TM) products are needed, to promote health and wellness. Clifton trades on the U.S. OTC: (CFTN). Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance. DATASOURCE: Clifton Mining Company CONTACT: Dr. Ken Friedman, President at (303) 642-0659; Keith Moeller, Vice President at (801) 756-1414; or see our website at http://www.cliftonmining.com/

Copyright